Home Deuterated Building Blocks 84468-24-6
84468-24-6,MFCD00209852
Catalog No.:AA004VZ5

84468-24-6 | Isoquinoline,5-(1-piperazinylsulfonyl)-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
10mg
≥98%
in stock  
$268.00   $188.00
- +
50mg
≥98%
in stock  
$906.00   $634.00
- +
100mg
≥98%
in stock  
$1,649.00   $1,154.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA004VZ5
Chemical Name:
Isoquinoline,5-(1-piperazinylsulfonyl)-
CAS Number:
84468-24-6
Molecular Formula:
C13H15N3O2S
Molecular Weight:
277.3421
MDL Number:
MFCD00209852
SMILES:
O=S(=O)(c1cccc2c1ccnc2)N1CCNCC1
Properties
Properties
 
Form:
Solid  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
401  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
2  
XLogP3:
0.6  

Downstream Synthesis Route

[1]CurrentPatentAssignee:HIDAKA;ASAHIKASEICORPORATION-US4456757,1984,A

[2]Ricouart,A.;Gesquiere,J.C.;Tartar,A.;Sergheraet,C.[JournalofMedicinalChemistry,1991,vol.34,#1,p.73-78]

[3]Martín-Cámara,Olmo;Arribas,Marina;Wells,Geoffrey;Morales-Tenorio,Marcos;Martín-Requero,Ángeles;Porras,Gracia;Martínez,Ana;Giorgi,Giorgio;López-Alvarado,Pilar;Lastres-Becker,Isabel;Menéndez,J.Carlos[JournalofMedicinalChemistry,2022,vol.65,#3,p.1867-1882]

[4]Collins,Ian;Caldwell,John;Fonseca,Tatiana;Donald,Alastair;Bavetsias,Vassilios;Hunter,Lisa-JaneK.;Garrett,MichelleD.;Rowlands,MartinG.;Aherne,G.Wynne;Davies,ThomasG.;Berdini,Valerio;Woodhead,StevenJ.;Davis,Deborah;Seavers,LisaC.A.;Wyatt,PaulG.;Workman,Paul;McDonald,Edward[BioorganicandMedicinalChemistry,2006,vol.14,#4,p.1255-1273]

[1]Morikawa;Sone;Asano[ChemicalandPharmaceuticalBulletin,1992,vol.40,#3,p.770-773]

[1]Ricouart,A.;Gesquiere,J.C.;Tartar,A.;Sergheraet,C.[JournalofMedicinalChemistry,1991,vol.34,#1,p.73-78]

[1]Ricouart,A.;Gesquiere,J.C.;Tartar,A.;Sergheraet,C.[JournalofMedicinalChemistry,1991,vol.34,#1,p.73-78]

[1]Morikawa;Sone;Asano[ChemicalandPharmaceuticalBulletin,1992,vol.40,#3,p.770-773]

Literature

Title: Evaluation of broad spectrum protein kinase inhibitors to probe the architecture of the malarial cyclin dependent protein kinase Pfmrk.

Journal: Bioorganic & medicinal chemistry letters 20070901

Title: Acridone derivatives are selective inhibitors of HIV-1 replication in chronically infected cells.

Journal: Antiviral research 19991001

Title: Isoquinolinesulphonamide derivatives inhibit transcriptional elongation of human immunodeficiency virus type 1 RNA in a promyelocytic model of latency.

Journal: Antiviral chemistry & chemotherapy 19990901

Title: P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro.

Journal: Genes & development 19971015

Title: Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists.

Journal: Journal of medicinal chemistry 19960607

Title: Hagiwara M, et al. Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives. Mol Pharmacol. 1987 Jul;32(1):7-12.

Title: Yu J, et, al. Efficient feeder-free episomal reprogramming with small molecules. PLoS One. 2011 Mar 1;6(3):e17557.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:84468-24-6 Molecular Formula|84468-24-6 MDL|84468-24-6 SMILES|84468-24-6 Isoquinoline,5-(1-piperazinylsulfonyl)-